US3689516A - Bis-carboxyethyl germanium sesquioxide and process for preparing same - Google Patents
Bis-carboxyethyl germanium sesquioxide and process for preparing same Download PDFInfo
- Publication number
- US3689516A US3689516A US805370A US3689516DA US3689516A US 3689516 A US3689516 A US 3689516A US 805370 A US805370 A US 805370A US 3689516D A US3689516D A US 3689516DA US 3689516 A US3689516 A US 3689516A
- Authority
- US
- United States
- Prior art keywords
- bis
- germanium sesquioxide
- trichlorogermanium
- compound
- carboxyethyl germanium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- PKCYYRXPGMHIPO-UHFFFAOYSA-N 4-[[3-carboxypropyl(oxo)germyl]oxy-oxogermyl]butanoic acid Chemical compound OC(=O)CCC[Ge](=O)O[Ge](=O)CCCC(O)=O PKCYYRXPGMHIPO-UHFFFAOYSA-N 0.000 title claims description 8
- 238000004519 manufacturing process Methods 0.000 title description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- GOWMQNMJCUAZRJ-UHFFFAOYSA-N propanoyl chloride;trichlorogermanium Chemical compound Cl[Ge](Cl)Cl.CCC(Cl)=O GOWMQNMJCUAZRJ-UHFFFAOYSA-N 0.000 claims description 4
- 235000019260 propionic acid Nutrition 0.000 claims description 3
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 230000003301 hydrolyzing effect Effects 0.000 claims 2
- -1 compound bis-carboxyethyl germanium sesquioxide Chemical class 0.000 abstract description 4
- 150000001875 compounds Chemical class 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 6
- 230000002159 abnormal effect Effects 0.000 description 6
- 229910052732 germanium Inorganic materials 0.000 description 6
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 6
- 239000000460 chlorine Substances 0.000 description 5
- 230000007062 hydrolysis Effects 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- 208000003468 Ehrlich Tumor Carcinoma Diseases 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 206010003445 Ascites Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 229940093626 germanium sesquioxide Drugs 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 210000004881 tumor cell Anatomy 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000002291 germanium compounds Chemical class 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 240000002234 Allium sativum Species 0.000 description 1
- FBEHFRAORPEGFH-UHFFFAOYSA-N Allyxycarb Chemical compound CNC(=O)OC1=CC(C)=C(N(CC=C)CC=C)C(C)=C1 FBEHFRAORPEGFH-UHFFFAOYSA-N 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015463 Lycium carolinianum Nutrition 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- PZYAYFPGUMSVJW-UHFFFAOYSA-N SSSSSSS Chemical compound SSSSSSS PZYAYFPGUMSVJW-UHFFFAOYSA-N 0.000 description 1
- 240000001085 Trapa natans Species 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- XMAVIGQLJRIJCG-UHFFFAOYSA-N bis(2-carboxyethyl)germanium Chemical compound OC(=O)CC[Ge]CCC(O)=O XMAVIGQLJRIJCG-UHFFFAOYSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229960005419 nitrogen Drugs 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- WMWJODDFMGJZHL-UHFFFAOYSA-N propanoic acid;trichlorogermanium Chemical compound Cl[Ge](Cl)Cl.CCC(O)=O WMWJODDFMGJZHL-UHFFFAOYSA-N 0.000 description 1
- 235000009165 saligot Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- YITSIQZHKDXQEI-UHFFFAOYSA-N trichlorogermanium Chemical compound Cl[Ge](Cl)Cl YITSIQZHKDXQEI-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/30—Germanium compounds
Definitions
- the compound of the invention inhibits the proliferation of Ehrlich ascites tumor cells.
- Germanium which has the atomic number of 32, is an atom having 32 electrons. Four of these electrons are located in an outer orbit and are unstable, being capable of separation from the rest under certain conditions. This property of germanium is utilized for transistors or diode rectifiers, as is popularly known. And there is a phenomenon that, when one of these four electrons has escaped, there results what is referred to as a positive hole of electric potential, to which other nearby electrons are drawn in. The composition of germanium being so, its organic compound is apt to cause electric charge transfer and to generate organic free radicals.
- Applicants have for a long time studied the components of plant substances used for the so-called Chinese medical herbs, which have been known to be effective to check abnormal cells in the living body, and discovered that they contained a very large content of germanium, for example, 320 ppm in ginseng, 257 ppm in water-caltrop nut, 124 ppm in box-thorn nut, 108 ppm in wisteriaknot, 50 ppm in pearlbarley seed, 58 ppm in erythrorhizon, 76 ppm in comfry, and 756 ppm in garlic. This fact appears to indicate that germanium exists within these plants in the form of organic compounds.
- B-cyanoethyltrichlorogermanium trichlorogermanium ethylene cyanide is obtained by the action of acrylonitrile on the known compound trichlorogermanium (germaniumchloroform).
- B-Cyanoethyltrichlorogermanium is converted into B- trichlorogermanium propionic acid (trichlorogermanium propionic acid) by hydrolysis in the presence of a mineral acid and by the action of thionylchloride, this latter compound is converted to trichlorogermanium propionyl chloride. Hydrolysis of this compound with water produces bis-carboxylethyl germanium sesquioxide.
- Test mice DD Shizuoka, 4 weeks old.
- the administered group were very vigorous and had good appetite compared with the control group, showing no external appearance of reaction, the control group showed stagnant ascites whereas the administered group showed neither ascites stagnation nor bleeding, the proportion of the number of tumor cells in the bodies of the administered group was approximately 26 percent against percent in the bodies of the control group, and that there was a good indication of the effective checking of fissiparism.
- the compound, bis-carboxyethyl germanium sesquioxide is a, are white, crystalline powder, and capable of polymerization on heating. Its melting point is impossible to measure, since heating to a higher temperature causes decomposition. In water solution, the oxygen in germanium sesquioxide is hydrated and the hydrogen stimulates charge transfer, thus causing activation. 7
- the novel compound according to the present invention is of a very low order of toxicity.
- the LD in mice as determined by hypodermic injection is 3,5g/kg of body weight.
- the compound of the invention is soluble in water, and therefore it is most convenient to formulate it as solutions in sterile, pyrogen-free water, although any pharmaceutically acceptable carrier may be used.
- a preferred therapeutic composition of the invention will comprise an aqueous solution containing from 0.01 to 0.4 by weight of the active ingredient.
- compositions containing the compound according to the invention can be administered orally or Number of E.A.'I. Ascites amount, Aver- '1.I.,
- Example l To 18 gr. of germaniumchloroform are added 6 gr. of acrylonitrile, and by heating under an atmosphere of 55 nitrogengas, Byanoethyltrichlorogermanium is obtained. This is converted to B-trichlorogermanium propionic acid by adding hydrochloric acid solution and heating. This is converted through reaction upon the dropwise addition of 12 gr. of thionylchloride, to trichlorogermanium propionyl chloride, which is recovered by distillation in vacuo. After complete hydrolysis takes place with water, bis-carboxyethyl germanium sesquioxide is obtained. This is washed with water until chlorine reaction disappears and a white powder is obtained. The yield is about 6 gr. Anal. calcd. for C,l-l ,O,(I1E Calculated value: 1 H2294, Ge:42.64 Found 113.00, Ge:42.41
- the carrier can be a solid and in the form of a powder or tablet.
- the solid carrier can be any of those commonly used in making medicinal formulations.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008568 | 1968-03-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
US3689516A true US3689516A (en) | 1972-09-05 |
Family
ID=12017251
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US805370A Expired - Lifetime US3689516A (en) | 1968-03-29 | 1969-03-07 | Bis-carboxyethyl germanium sesquioxide and process for preparing same |
Country Status (7)
Country | Link |
---|---|
US (1) | US3689516A (fr) |
BE (1) | BE730615A (fr) |
CH (1) | CH521376A (fr) |
DE (1) | DE1793288B1 (fr) |
FR (1) | FR2005110A1 (fr) |
GB (1) | GB1257225A (fr) |
NL (1) | NL6904836A (fr) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4066678A (en) * | 1975-10-23 | 1978-01-03 | Ryuichi Sato | 3-trihydroxygermyl propionic acid and its salts and a process for the production thereof |
US4271084A (en) * | 1978-03-01 | 1981-06-02 | Ryuichi Sato | Germanium-containing organic polymer and the process for the production of the same |
US4361579A (en) * | 1979-09-19 | 1982-11-30 | Yoshitomi Pharmaceutical Industries, Ltd. | Organogermanium compounds |
EP0085513A1 (fr) * | 1982-02-01 | 1983-08-10 | Industrial Technology Research Institute | Procédé de préparation de dérivés d'acides organogermanium propioniques |
US4508654A (en) * | 1982-02-01 | 1985-04-02 | Industrial Technology Research Institute | Preparation of bis-carboxy ethyl germanium sesquioxide and its propionic acid derivatives |
DE3514659A1 (de) * | 1984-04-25 | 1985-10-31 | Asai Germanium Research Institute, Tokio/Tokyo | Antioxidans |
US4579961A (en) * | 1982-08-23 | 1986-04-01 | Norihiro Kakimoto | Organogermanium compounds having both hydrophilicity and lipophilicity and process for producing the same |
US4956272A (en) * | 1987-10-29 | 1990-09-11 | Asai Germanium Research Institute Co., Ltd. | Organogermanium containing solution for washing and storing separated organs |
US5006553A (en) * | 1987-10-29 | 1991-04-09 | Asai Germanium Research Institute Co., Ltd. | Agent for improving reduced functions of organs caused by inhibited blood circulation |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3812167A (en) * | 1971-08-27 | 1974-05-21 | Pahk Heart Foundation | Germanium derivative |
JPS5473129A (en) * | 1977-11-22 | 1979-06-12 | Asai Germanium Res Inst | External skin remedy |
JPS55122717A (en) * | 1979-03-15 | 1980-09-20 | Asai Gerumaniumu Kenkyusho:Kk | Interferon inducer |
JPS6016924A (ja) * | 1983-07-11 | 1985-01-28 | Asai Gerumaniumu Kenkyusho:Kk | 抗腫瘍剤 |
JP2698870B2 (ja) * | 1987-10-29 | 1998-01-19 | 株式会社浅井ゲルマニウム研究所 | シクロスポリンの投与による腎毒性の軽減剤 |
US5008416A (en) * | 1989-06-20 | 1991-04-16 | Sanwa Kagaku Kenkyusho Co., Ltd. | Organogermanium compound, process for the preparation of same as well as use thereof |
-
1968
- 1968-08-27 DE DE19681793288 patent/DE1793288B1/de active Pending
- 1968-10-21 CH CH1569168A patent/CH521376A/de not_active IP Right Cessation
-
1969
- 1969-03-07 US US805370A patent/US3689516A/en not_active Expired - Lifetime
- 1969-03-28 BE BE730615D patent/BE730615A/xx not_active IP Right Cessation
- 1969-03-28 FR FR6909416A patent/FR2005110A1/fr active Pending
- 1969-03-28 NL NL6904836A patent/NL6904836A/xx unknown
- 1969-03-31 GB GB1257225D patent/GB1257225A/en not_active Expired
Non-Patent Citations (1)
Title |
---|
Lesbre et al. Compt. Rend. Vol. 247 (1958) p. 471 474 * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4066678A (en) * | 1975-10-23 | 1978-01-03 | Ryuichi Sato | 3-trihydroxygermyl propionic acid and its salts and a process for the production thereof |
US4271084A (en) * | 1978-03-01 | 1981-06-02 | Ryuichi Sato | Germanium-containing organic polymer and the process for the production of the same |
US4361579A (en) * | 1979-09-19 | 1982-11-30 | Yoshitomi Pharmaceutical Industries, Ltd. | Organogermanium compounds |
EP0085513A1 (fr) * | 1982-02-01 | 1983-08-10 | Industrial Technology Research Institute | Procédé de préparation de dérivés d'acides organogermanium propioniques |
US4420430A (en) * | 1982-02-01 | 1983-12-13 | Industrial Technology Research Institute | Method for preparing organo germanium propionic acid derivatives |
US4508654A (en) * | 1982-02-01 | 1985-04-02 | Industrial Technology Research Institute | Preparation of bis-carboxy ethyl germanium sesquioxide and its propionic acid derivatives |
US4579961A (en) * | 1982-08-23 | 1986-04-01 | Norihiro Kakimoto | Organogermanium compounds having both hydrophilicity and lipophilicity and process for producing the same |
DE3514659A1 (de) * | 1984-04-25 | 1985-10-31 | Asai Germanium Research Institute, Tokio/Tokyo | Antioxidans |
US4720564A (en) * | 1984-04-25 | 1988-01-19 | Asai Germanium Research Institute | Antioxidant organogermanium compound |
US4956272A (en) * | 1987-10-29 | 1990-09-11 | Asai Germanium Research Institute Co., Ltd. | Organogermanium containing solution for washing and storing separated organs |
US5006553A (en) * | 1987-10-29 | 1991-04-09 | Asai Germanium Research Institute Co., Ltd. | Agent for improving reduced functions of organs caused by inhibited blood circulation |
Also Published As
Publication number | Publication date |
---|---|
NL6904836A (fr) | 1969-10-01 |
CH521376A (de) | 1972-04-15 |
BE730615A (fr) | 1969-09-01 |
FR2005110A1 (fr) | 1969-12-05 |
GB1257225A (fr) | 1971-12-15 |
DE1793288B1 (de) | 1971-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3689516A (en) | Bis-carboxyethyl germanium sesquioxide and process for preparing same | |
Bergman et al. | Two new groups of selective stimulants of adrenergic β-receptors | |
Storer et al. | Protective effect of para-aminopropiophenone against lethal doses of X-radiation | |
US5025035A (en) | Method of treating depression | |
EP0049852B1 (fr) | Formulation pharmaceutique et sa préparation | |
EP0324154A2 (fr) | Complexes du platine avec le 1,2 bis(aminométhyl)cyclobutane | |
LU83982A1 (de) | Platin-diamin-komplexe,ein verfahren zu ihrer herstellung,ein verfahren zur herstellung eines arzneimittels unter einsatz eines derartigen platin-diamin-komplexes fuer die behandlung von krebs sowie das dabei erhaltene arzneimittel | |
US2761807A (en) | Glycocyamine and methylating agent in vivo creatine producing composition | |
DE3425404C2 (de) | Verwendung von Germaniumsesquisulfiden als Antineoplastikum | |
US2561468A (en) | p-n-mono- and disubstituted aminohydroxyalkylbenzoates and processes of producing same | |
US3988461A (en) | Pharmaceutical composition for the treatment of Parkinson's disease | |
DE3424107A1 (de) | Organogermaniumverbindung und diese als wirkstoff enthaltender opioidpeptidaseinhibitor | |
US2507468A (en) | Monobasic phosphate of 1-phenyl-2-aminopropane | |
US2899359A (en) | tetrahydrodiazepine | |
US2939817A (en) | Method of treating diseases associated with plasmin activity | |
HU176505B (en) | Process for producing new n-bracket-2-comma above-carboxy-phenyl-bracket closed-4-chloro-antranylic acid derivatives | |
US4241084A (en) | Antibacterial and antifungal compositions | |
US3439091A (en) | Method of treatment with modified tetracycline compounds and composition therefor | |
GB1272337A (en) | New basic carbamates and preparation thereof | |
DE3143592C2 (de) | Quaternäre N,N&uarr;3&uarr;-Di(ß-brompropionyl)-N',N&uarr;2&uarr;-dispirotripiperaziniumsalze, Verfahren zu deren Herstellung und Arzneimittel mit zytostatischer Wirkung | |
EP0071903B1 (fr) | Composés diglycidyl ptéridiniques, procédés pour leur préparation et leur utilisation dans des médicaments à activité cytostatique | |
US3436458A (en) | Antispasmodic and gastric antisecretory compositions containing rho-phenylphenacyl derivatives of 1-hyoscyamine and d,1-tropylatropine | |
Hunt | Notes on Acetyl-Methyl-Choline | |
JPH04264092A (ja) | シクロトリホスファゼンのn,oスピロ環状誘導体とその製法および用途 | |
US3345415A (en) | N-n-alkylaminoethanethiols |